HGH vs PPS

ASX Financial Services sector comparison — updated 25 Mar 2026 — Financial Services sector

HGH

HEARTLAND FPO NZX [HGH]

53MEDIUM

PPS

PRAEMIUM FPO [PPS]

53MEDIUM

Score Breakdown

HGH PPS
Technical
55
56
Catalyst
51
70
Sentiment
50
50
Fundamental
94
100
Momentum
80
72
Risk Gate
42
50

Key Metrics

HGH Metric PPS
$1.0BMarket Cap$312.0M
9KAvg Volume (20d)1.1M
N/AShort Interest+0.1%
$1.11052-Week High$0.945
$0.66052-Week Low$0.555
+0.0%Daily Change+2.7%
$0.985Entry Price$0.657
+6.7%ROE+15.7%
+27.2%Profit Margin+16.2%

Active Signals

HGH Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Volume surging at 5.4x normal while price falls — heavy selling pressure
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 3.4% over the last 5 days

PPS Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Volume surging at 2.5x normal while price climbs — real buying conviction behind this move
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (2.9x)
Moderate revenue growth (+11%)

Ask Scout AI to compare HGH and PPS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
HGH Full Analysis → PPS Full Analysis → Financial Services Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).